Stock Market Drops After Trumps Biotech Pricing Comments, Impressive Come Back

Stock-Markets / Stock Market 2017 Jan 12, 2017 - 06:32 AM GMT

The stock market had a very volatile day today as the indices went up in the morning, down in the afternoon on news that Trump is going to make the biotech companies accountable for pricing, rallied back up, came back down to retest, held, and then put on a very impressive afternoon rally that took the indices back into the plus column, to close up on the day.

Net on the day, the Dow was up 98.75 at 19,954.28, 19 points off the high. The S&P 500 was up 6.42 at 2275.32, right at the high for the day. The Nasdaq 100 was up 15.04 at 5050.21, also at the high for the day, 38 points off the low.

Advance-declines were 20 to 9 positive on the New York Stock Exchange, and 5 to 4 positive on the Nasdaq. Up/down volume was almost 2 to 1 positive on New York, total volume of 3 1/2 billion shares traded. The Nasdaq traded 1.7 billion shares and had an 11 to 8 positive volume ratio.

TheTechTrader.com board was very mixed today. Priceline.com (PCLN) was up 86 cents to 1536.11, Alphabet Inc. (GOOG) up 3.12 to 807.91, Apple Inc. (AAPL) up 64 cents to 119.75, Amazon.com, Inc. (AMZN) 3.12 to 799.03, and Netflix, Inc. (NFLX) 61 cents to 130.50.

Baidu, Inc. (BIDU) lost 1.00 to 179.31, Facebook, Inc. (FB) gained 1.74 to 126.09, and First Solar, Inc. (FSLR) advanced 1.61 to 35.00.

Tesla Motors, Inc. (TSLA) dropped 14 cents to 229.73.

Other stocks to the upside included Argan, Inc. (AGX) up 1.00 to 70.35, Exact Sciences Corporation (EXAS) up 1.09 to 18.66.

On the downside, NVIDIA Corporation (NVDA) was down another 1.31 to 105.16, NeuroDerm Ltd. (NDRM) down 1.00 to 20.90, Clovis Oncology Inc (CLVS) down 1.05 to 49.33, CoLucid Pharmaceuticals, Inc. (CLCD) 1.45 to 33.55, and Aerie Pharmaceuticals, Inc. (AERI) 1.05 to 38.80.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) had a very tough session, down 4.51 to 37.90, but the low is another point below that.

Checking TheTechTrader.com percent-gain leaderboard, Uranium Resources, Inc. (URRE) climbed 94 cents, or 42%, to 3.19, on 25.5 million shares traded. Biocept, Inc. (BIOC) popped 90 cents, or 50%, to 2.71, on 63 million shares traded. AXT Inc. (AXTI) bounced 50 cents, or 10%, to 5.80.

MYOS RENS Technology Inc. (MYOS) jumped 5.52, or 425%, to 6.82, 16 million shares traded, or 85,000% more volume than average.

AXIM Biotechnologies, Inc. (AXIM) ran 3.26, or 28%, to 15.00. Kornit Digital Ltd. (KRNT) bounced 2.85, or 20%, to 16.80, on 1.75 million shares traded, reaching as high as 17.50 at one point.

The Direxion Daily S&P Biotech Bear 3X ETF (LABD) closed up 1.41, or 10%, to 14.96.

Among other gainers, Workday, Inc. (WDAY) had a big day today, up 7.35 to 81.70, and Teck Resources Limited (TECK) was up 1.57 to 23.98.

Stepping back and reviewing the hourly chart patterns, the indices were up a little in the morning, they got slammed back down, came back strongly, retested the lows, and then had a very strong, late rally, closing at the highs for the day.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.